Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/22/2025

Azithromycin Safety for Atypical Pneumonia in Pregnancy

Safety Profile and Recommendation Basis

  • The Centers for Disease Control and Prevention (CDC) recommends azithromycin as the preferred macrolide antibiotic for treating atypical pneumonia during pregnancy, including the first trimester, due to its safety profile 1
  • Azithromycin is the drug of choice among macrolides for pregnant women requiring treatment for atypical bacterial infections, based on animal studies showing no teratogenic effects and no conclusive evidence of adverse fetal outcomes in human use 2, 3, 4
  • The CDC specifically designates azithromycin as preferred over other macrolides, such as clarithromycin, which has demonstrated birth defects in animal models 2, 3, 4

Treatment Approach for Atypical Pneumonia

  • The CDC recommends azithromycin as the first-line agent for outpatient management of atypical pneumonia in pregnant women, with a standard dosing regimen of 500 mg on day 1, followed by 250 mg daily for days 2-5 4, 1, 5
  • For inpatient management, azithromycin combined with a beta-lactam antibiotic, such as ampicillin or ceftriaxone, is recommended for more severe presentations 4, 6

Critical Safety Distinction: Avoid Clarithromycin

  • Clarithromycin is not recommended as first-line therapy in pregnancy due to increased risk of birth defects in animal studies and possible increased risk of spontaneous abortion in human studies 2, 3, 4
  • The CDC classifies clarithromycin as DIII (should not be used) for pregnant women, emphasizing that azithromycin and clarithromycin are not interchangeable in pregnancy 2, 1

Monitoring and Special Considerations

  • Pregnancy-specific monitoring includes watching for preterm labor after 20 weeks gestation, as pneumonia increases the risk of preterm delivery, and ensuring appropriate shielding during chest radiography 4
  • The FDA warns of QT prolongation risk, hepatotoxicity, and Clostridium difficile-associated diarrhea risk with azithromycin use, applicable to all patients, including pregnant women 4

Common Pitfalls to Avoid

  • Withholding azithromycin in the first trimester out of excessive caution is not recommended, as it is specifically recommended for use throughout pregnancy when clinically indicated 1
  • Substituting clarithromycin for azithromycin is not advised due to their different safety profiles in pregnancy 2, 1
  • Using doxycycline during pregnancy is not recommended due to hepatotoxicity risk and fetal tooth/bone staining 4

Alternative Considerations

  • If azithromycin cannot be used, erythromycin is an acceptable alternative, though with more gastrointestinal side effects, and fluoroquinolones (levofloxacin) can be used for serious infections when other options fail, with approximately 400 cases of quinolone use in pregnancy not showing increased arthropathy or birth defects 4

Azithromycin for Community-Acquired Pneumonia in Pregnancy

Treatment Algorithm for Pregnant Women

  • The American Thoracic Society recommends combination therapy with a beta-lactam PLUS azithromycin 500 mg daily for pregnant women requiring hospitalization with pneumonia, with beta-lactam options including ampicillin-sulbactam, ceftriaxone, or cefotaxime 7

Pathogen Coverage and Efficacy

  • Azithromycin provides excellent coverage for the most common pneumonia pathogens in pregnancy, including Streptococcus pneumoniae, Haemophilus influenzae, and atypical organisms, with clinical trials demonstrating 97-98% bacteriological eradication rates for S. pneumoniae and 80% nasopharynx eradication for C. pneumoniae 8

REFERENCES

1

Azithromycin Safety in First Trimester of Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

recommendations and guidelines for the treatment of pneumonia in taiwan. [LINK]

Journal of Microbiology, Immunology and Infection, 2019